Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

  • June 2025 quarter CPI no roadblock to August RBA rate cut
    June 2025 quarter CPI no roadblock to August RBA rate cut
    • News

  • Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    • News

  • Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    • News

  • Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    • News

  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    • News

  • dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    • News

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

InvoCare gets second acquisition offer from TPG, this time with confidentiality

  • In News
  • May 15, 2023
  • Alinda Gupta
InvoCare gets second acquisition offer from TPG, this time with confidentiality

Funeral services company InvoCare Limited (ASX: IVC) has received a revised proposal from private equity company TPG Capital Global regarding the potential acquisition of all the issued capital of InvoCare. This revised proposal comes after an unsuccessful attempt by TPG last month.

Previously, TPG made an offer InvoCare simply could refuse. The Company found the terms to be unconvincing and therefore declined. However, InvoCare did grant TPG access to limited, non-public financial information on a non-exclusive basis to assist them in formulating a revised proposal. Unfortunately, TPG did not sign the customary confidentiality agreement to access this information nor provide InvoCare with a revised proposal for consideration. 

The revised proposal from TPG follows a period of engagement between the two parties after TPG’s unsolicited initial proposal was received on March 7, 2023. The initial proposal was valued at $12.65 per InvoCare share, but it was later withdrawn on April 24, 2023. The revised proposal, however, puts forward an equity value of $1.9 billion and an enterprise value of $2.2 billion, offering $13.00 per share in cash.

The revised proposal includes several significant premiums. It represents a 45.3% premium to InvoCare’s undisturbed closing share price of $8.95 per share on March 6, 2023. Additionally, it offers a 39.2% premium to InvoCare’s trading VWAP (Volume-Weighted Average Price) of $9.34 per share following the release of its FY22 results on February 27, 2023, and before receiving TPG’s offer on March 7, 2023. Lastly, it presents a 32.4% premium to InvoCare’s one-month VWAP of $9.82 per share on March 6, 2023. The revised proposal also permits InvoCare to pay a fully franked special dividend of approximately $0.60 per share before the transaction takes place.

If a Special Dividend is paid, the amount of money shareholders receive as part of the scheme consideration will be reduced by the cash value of the dividend. Shareholders who can make full use of franking credits are likely to benefit from around $0.25 in franking credits for each share they own in InvoCare. Taking these factors into account, the Revised Proposal could be worth up to about $13.25 per share for shareholders who can use franking credits.

After a careful evaluation of the Revised Proposal and upon TPG signing a Confidentiality and Process Agreement, the InvoCare Board has agreed to grant TPG an exclusive five-week period to conduct due diligence starting from the date the Process Agreement is signed. TPG also has the option to extend the exclusivity period by an additional two weeks if, at the end of the initial period, TPG reaffirms the Revised Proposal and continues to work cooperatively with InvoCare towards entering into a scheme implementation deed.

Should TPG submit a binding proposal of no less than $13.00 per InvoCare share, the InvoCare Board intends to unanimously recommend that InvoCare shareholders vote in favour of the proposed scheme of arrangement. That’s if there’s no superior proposal.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • ASX IVC
  • funeral services
  • InvoCare Limited
  • takeover
  • TPG Capital Global
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.